Literature DB >> 22464899

Elderly patients with aneurysmal subarachnoid hemorrhage: Coils but also clips.

S Derrey1, S Curey, P Hannequin, H Castel, O Langlois, E Tollard, P Fréger, F Proust.   

Abstract

The ageing of the population in good health or without severe morbidity expose them to the occurrence of a subarachnoid hemorrhage (SAH) and requires effective management. Currently, the pertinence of cerebral aneurysm treatment by clipping or coiling is accepted for patients in the 8th or 9th decade of life, and the risk of postoperative morbidity induced by our therapeutic alternative must be carefully assessed. In these decades, the female/male sex ratio for aneurysmal SAH was greater in female who had a 1.6 times higher ratio than in male. The initial clinical status did not appear worse with age despite the frequent severity of bleeding observed on CT scan probably due to the large subarachnoid space. The aneurysm distribution and size were similar to those classically reported in the global population. The endovascular (EV) coiling appears as the first option with a favorable outcome rate estimated at 48% to 63%. Nevertheless, the benefit of EV coiling compared to microsurgical clipping for treatment of ruptured aneurysm in the elderly has not been demonstrated in a large randomized study. This is the reason why the vascular section of the French Society of Neurosurgery developed a prospective and randomized study of the aneurysmal SAH (PHRC 2007-042/HP) on the elderly patients.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22464899     DOI: 10.1016/j.neuchi.2012.02.014

Source DB:  PubMed          Journal:  Neurochirurgie        ISSN: 0028-3770            Impact factor:   1.553


  1 in total

1.  Surgical Management of Unruptured Cerebral Aneurysms in the Elderly: An Institution Experience.

Authors:  Abderrahmane Cheikh; Sudhakar Kasinathan; Yamada Yasuhiro; Tsukasa Kawase; Yoko Kato
Journal:  Asian J Neurosurg       Date:  2019 Jul-Sep
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.